Prospect Capital Corp
Change company Symbol lookup
Select an option...
PSEC Prospect Capital Corp
SPEC Spectralcast Inc
RC Ready Capital Corp
GNK Genco Shipping & Trading Ltd
NVOS Novo Integrated Sciences Inc
PDRDF Pernod Ricard SA
RKDA Arcadia Biosciences Inc
BBVA Banco Bilbao Vizcaya Argentaria SA
GIC Global Industrial Co
EQHA EQ Health Acquisition Corp
Go

Financials : Capital Markets | Small Cap Blend
Company profile

Prospect Capital Corporation is a financial services company that primarily lends to and invests in middle-market privately held companies. The Company's investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. It invests primarily in senior and subordinated secured debt and equity of private companies in need of capital for acquisitions, divestitures, growth, development, recapitalizations and other purposes. It makes directly originated agented loans to companies, including companies which are controlled by private equity sponsors and companies that are not controlled by private equity sponsors. It also invests in senior and secured loans, syndicated loans and high yield bonds that have been sold to a club or syndicate of buyers, both in the primary and secondary markets. The Company is managed by its investment adviser, Prospect Capital Management L.P.

Closing Price
$7.39
Day's Change
-0.20 (-2.64%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.67
Day's Low
7.31
Volume
(Average)
Volume:
2,430,421

10-day average volume:
2,303,263
2,430,421

Thermo Fisher Scientific Inc. Stock Outperforms Competitors Despite Losses On The Day

5:26 pm ET January 7, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Thermo Fisher Scientific Inc. (TMO) slipped 2.15% to $607.07 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.41% to 4,677.03 and Dow Jones Industrial Average falling 0.01% to 36,231.66. The stock's fall snapped a two-day winning streak. Thermo Fisher Scientific Inc. closed $65.27 short of its 52-week high ($672.34), which the company achieved on December 31st.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Danaher Corp. (DHR) fell 2.71% to $295.67, Intuitive Surgical Inc. (ISRG) fell 2.96% to $324.29, and Becton Dickinson & Co. (BDX) rose 1.77% to $254.15. Trading volume (1.7 M) eclipsed its 50-day average volume of 1.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 7, 2022.

-MarketWatch Automation

	

(END) Dow Jones Newswires

January 07, 2022 17:26 ET (22:26 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.